Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H D Bruhn

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Der Internist|April 1, 1983
[Plasma prekallikrein: determination using a chromogenic substrate. Studies of clinico-diagnostic relevance]H D Bruhn
Der Internist|July 2, 1998
[APC resistance. Significance--diagnosis--therapeutic consequences]H D Bruhn
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1971
[Salicylic acid derivatives used as anticoagulants]H D Bruhn
Die Medizinische Welt|November 11, 1972
[Dependence of euglobulinolysis time from the plasma platelet content]H D Bruhn
Deutsche Medizinische Wochenschrift (1946)|June 28, 1974
[New findings concerning the anti-streptokinase titre in relation to a streptokinase-induced thrombolytic therapy (author's transl)]H D Bruhn
Deutsche Medizinische Wochenschrift (1946)|February 14, 1997
[Anticoagulation in transitory ischemic attack after bypass surgery]H D Bruhn
Thrombosis and Haemostasis|December 23, 1981
Growth regulation of vessel wall cells and of tumor cells by thrombin, factor XIII and fibronectinH D Bruhn
Der Internist|May 1, 1997
["White clot syndrome"]H D Bruhn
ZFA. Zeitschrift Fur Allgemeinmedizin|February 10, 1983
[Prevention of chronic venous insufficiency]H D Bruhn
Die Medizinische Welt|January 15, 1982
[Heparin, streptokinase or surgical therapy in manifest thromboembolic diseases]H D Bruhn
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Der Internist|April 1, 1983
[Plasma prekallikrein: determination using a chromogenic substrate. Studies of clinico-diagnostic relevance]H D Bruhn
Der Internist|July 2, 1998
[APC resistance. Significance--diagnosis--therapeutic consequences]H D Bruhn
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1971
[Salicylic acid derivatives used as anticoagulants]H D Bruhn
Die Medizinische Welt|November 11, 1972
[Dependence of euglobulinolysis time from the plasma platelet content]H D Bruhn
Deutsche Medizinische Wochenschrift (1946)|June 28, 1974
[New findings concerning the anti-streptokinase titre in relation to a streptokinase-induced thrombolytic therapy (author's transl)]H D Bruhn
Deutsche Medizinische Wochenschrift (1946)|February 14, 1997
[Anticoagulation in transitory ischemic attack after bypass surgery]H D Bruhn
Thrombosis and Haemostasis|December 23, 1981
Growth regulation of vessel wall cells and of tumor cells by thrombin, factor XIII and fibronectinH D Bruhn
Der Internist|May 1, 1997
["White clot syndrome"]H D Bruhn
ZFA. Zeitschrift Fur Allgemeinmedizin|February 10, 1983
[Prevention of chronic venous insufficiency]H D Bruhn
Die Medizinische Welt|January 15, 1982
[Heparin, streptokinase or surgical therapy in manifest thromboembolic diseases]H D Bruhn
Pageof 10